Bio-Rad Laboratories Appoints New Executive VP for Growth
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Bio-Rad Laboratories ( (BIO) ) has shared an announcement.
Bio-Rad Laboratories announced the appointment of Rajat Mehta as Executive Vice President, Global Commercial Operations, effective August 4, 2025, following the retirement of Mike Crowley after a 26-year tenure. Mehta brings extensive leadership experience from Labcorp and Thermo Fisher Scientific, and his appointment is expected to drive Bio-Rad’s global commercial strategy and long-term growth, enhancing its position in the life science and clinical diagnostics markets.
The most recent analyst rating on (BIO) stock is a Buy with a $390.00 price target. To see the full list of analyst forecasts on Bio-Rad Laboratories stock, see the BIO Stock Forecast page.
Spark’s Take on BIO Stock
According to Spark, TipRanks’ AI Analyst, BIO is a Neutral.
Bio-Rad Laboratories’ overall score reflects significant financial challenges due to declining revenues and negative profitability indicators. While technical indicators show some positive momentum, valuation concerns and macroeconomic headwinds weigh heavily. The strategic acquisition of Stilla Technologies offers potential growth opportunities, but operational inefficiencies and the impact of tariffs remain substantial risks.
To see Spark’s full report on BIO stock, click here.
More about Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, the company operates a global network of research, development, manufacturing, and sales operations with approximately 7,500 employees and $2.6 billion in revenues in 2024. Its customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety, and environmental quality laboratories.
Average Trading Volume: 351,557
Technical Sentiment Signal: Sell
Current Market Cap: $7.19B
See more insights into BIO stock on TipRanks’ Stock Analysis page.
